Prevalence, admission rates and hypoxia due to COVID-19 in patients with rheumatic disorders treated with targeted synthetic or biologic disease modifying antirheumatic drugs or methotrexate: a nationwide study from Iceland
نویسندگان
چکیده
Abstract Background and objectives: Misdiagnosis of psychogenic nonepileptic seizures (PNES) epileptic (ES) is common. In the absence diagnostic gold standard (video EEG), clinicians rely on semiology clinical assessment. However, questions regarding accuracy different signs remain. This meta-analysis aims to evaluate in PNES ES. Methods: We systematically searched PubMed, PsycInfo Medline for original research publications published before 8 February 2021 with no restriction search dates identify studies that compared ES epilepsy monitoring units. Non-English publications, review articles, reporting only or limited patients developmental delay were excluded. Study characteristics proportions ‘event groups’ ‘patient demonstrating extracted from each article. Bivariate analysis was conducted, data pooled a random effects model meta-analysis. The I2 statistic calculated assess statistical heterogeneity. QUADAS-2 tool utilized risk bias included studies. positive likelihood ratio (PLR) negative (NLR) calculated. A PLR > 10 an NLR < 0.1 has large impact post-test probability diagnosis (ES PNES) whereas between 5-10 0.1- 0.2 moderate PNES). Results: 14 comprising 800 452 PNES. For PNES, ictal eye closure (PLR 40.5 95%CI: 16.2-101.3; = 0, three studies) asynchronous limb movements 10.2; 2.8-37.7; reached threshold 5. No single sign >5 Conclusions: While all require interpretation overall context, presence are reliable discriminative
منابع مشابه
Biologic Disease-Modifying Antirheumatic Drugs
1. Distinguish between biologic DMARD use and nonbiologic DMARD use in the treatment of rheumatoid arthritis (RA). 2. Assess the differences between classes of biologic disease-modifying antirheumatic drug (DMARD) therapy. 3. Based on individual patient characteristics, construct a treatment and monitoring plan for a patient with RA and, when appropriate, include biologic DMARD therapy. 4. Just...
متن کاملTaking Renin-Angiotensin Drugs in Patients with COVID-19: Start, Continue, or Stop; a Literature Review
Considering the pandemic of the COVID-19 disease, the use of various drugs in patients has been investigated. Recently, numerous studies have been done on the effectiveness of drugs which used to treat the underlying disease such as congestive heart failure, hypertension, as well as coronary artery disease in various countries, because the patients with underlying conditions are more likely ...
متن کاملBaricitinib, Methotrexate, or Combination in Patients With Rheumatoid Arthritis and No or Limited Prior Disease‐Modifying Antirheumatic Drug Treatment
OBJECTIVE We undertook this phase III study to evaluate baricitinib, an orally administered JAK-1/JAK-2 inhibitor, as monotherapy or combined with methotrexate (MTX) compared to MTX monotherapy in patients with active rheumatoid arthritis (RA) who had received no or minimal conventional synthetic disease-modifying antirheumatic drugs (DMARDs) and who were naive to biologic DMARDs. METHODS A t...
متن کاملPrevalence of Psychological Disorders in Patients with COVID-19 Syndrome
A B S T R A C T The coronavirus 2019 first broke out on December 17, 2019 in Wuhan, China, and on March 11, 2020, it was announced as a worldwide pandemic by the World Health Organization. Despite nutritious diets and promising vaccines, health tips such as wearing a mask, social distancing, home quarantine, and not traveling are still the best ways to control the spread of COVID-19.While the ...
متن کاملTreatment patterns in psoriatic arthritis patients newly initiated on oral nonbiologic or biologic disease-modifying antirheumatic drugs
INTRODUCTION This study aimed to describe treatment changes (discontinuation, switching, and therapy add-on) following the initiation of biologic or nonbiologic oral disease-modifying antirheumatic drugs (DMARDs) in psoriatic arthritis (PsA) patients. METHODS Adult patients with ≥2 PsA diagnoses from physician office visits, initiated on a biologic or nonbiologic oral DMARD, were selected fro...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Annals of the Rheumatic Diseases
سال: 2021
ISSN: ['1468-2060', '0003-4967']
DOI: https://doi.org/10.1136/annrheumdis-2020-219564